| 标题 |
Phase Ib and dose-expansion study of GSK3326595, a PRMT5 inhibitor as monotherapy and in combination with pembrolizumab in patients with advanced cancers |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:M.M. Gounder; Patricia Martín-Romano; A. Italiano; L. L. Siu; Philippe A. Cassier; et al 出版日期:2025-09-10 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)